首页> 美国卫生研究院文献>Annals of Surgery >The use of stabilized human umbilical vein for femoropopliteal bypass. Experience with 133 operations with 5-year follow-up.
【2h】

The use of stabilized human umbilical vein for femoropopliteal bypass. Experience with 133 operations with 5-year follow-up.

机译:使用稳定的人脐静脉进行股pop旁路。有133次手术的经验,并进行了5年的随访。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

One hundred thirty-three femoropopliteal bypasses using stabilized human umbilical vein were performed in 116 patients during a 5-year period. The indications for operation were claudication in 35% and limb salvage in 65%. There were eight deaths in the postoperative period, all due to myocardial infarctions, and all occurring in patients operated upon for limb salvage. Patients operated upon for claudication had a cumulative patency rate of 83% at 1 year and 63.5% at 5 years, while patients operated upon for limb salvage had patency rates of 66% and 50% at 1 and 5 years. Diabetics had a patency rate of 69% at 5 years. The quality of arteriographic runoff was the leading determinant of patency in all groups. Two instances of aneurysmal degeneration of the graft were seen, both 5 years after implantation, and two graft infections were observed.
机译:在5年的时间里,对116例患者使用了稳定的人脐静脉进行了133次股poplite旁路术。手术指征为c行者占35%,肢体抢救者占65%。术后有8例死亡,均是由于心肌梗塞造成的,且均发生在进行肢体抢救手术的患者中。进行c行手术的患者在1年时的累积通畅率为83%,在5年时为63.5%,而进行肢体抢救的患者在1年和5年时的通畅率分别为66%和50%。糖尿病患者5年的通畅率为69%。动脉血流量的质量是所有组通畅性的主要决定因素。均在植入后5年内观察到2例移植物的动脉瘤变性,并观察到2例移植物感染。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号